Sarepta Therapeutics SRPT announced that the FDA has granted platform-technology designation to its viral vector rAAVrh74, ...

In this case, the company tested a vector based on a virus from the Betatorquevirus genus. In the new study, Ring tested its Anellovector’s ability to deliver a gene expressing a fluorescent ...

Based on optical interference ... Principle of BLI. Image Credit: Gator Bio, Inc. Ensuring vector consistency and quality is critical to the success of gene therapies, but several key challenges ...

Vector isn’t the only biotech taking a so-called gutless approach to genetic medicines. Boston-based Ensoma is developing in vivo gene therapies delivered by adenoviruses stripped of viral ...

The first vector-delivered ... 82% of the gene therapies in development at the time were using AAV vectors.3 The next most popular technology, a system based on lentivirus vectors, is used by ...

Adobe also introduced new Firefly models specifically for Illustrator that let users create editable vector images based on text prompts. Vector graphics differ from bitmapped graphics (found in ...

The work, recently published in Analytical Chemistry, represents an exciting advancement for gene therapy. Recombinant adeno-associated virus (rAAV) is a promising vector for delivering ...

Wacker Biotech US, a CDMO, and Expression Manufacturing, which specializes in viral vector technology, agreed to collaborate to advance the development and manufacturing of lentiviral-based gene ...

Cell and gene therapies ... to supply them. Vector BioMed, a new CDMO with a focus on producing lentiviral vectors, is stepping up to fill the void. Gaithersburg, Maryland-based Vector BioMed ...

Vector Recoloring generates variations of vector images in different color schemes to help graphic designers select the best version for their project. Vector Recoloring generates variations of ...

Data on gene therapy with hematopoietic stem-cell (HSC)–based expression of factor VIII ... transduced with CD68-ET3-LV — a lentiviral vector including a new F8 transgene (ET3) with a myeloid ...